Varenicline’s anti-inflammatory effectiveness in lung and brain tissues in mice with emphysema and stroke has been shown to occur by α7nAChR activation (Chen et al., 2017; Koga et al., 2018). This evidence concerns the gene CHRNA7 and pulmonary emphysema.